 CAMBRIDGE, Mass. MENLO PARK, Calif.--BUSINESS WIRE--Takeda Pharmaceutical Company Limited TSE:4502NYSE:TAK Takeda and Frazier Healthcare Partners Frazier today announced a collaboration to launch HilleVax, Inc. HilleVax, a biopharmaceutical company to develop and commercialize Takedas norovirus vaccine candidate. Takeda has granted a license to HilleVax for the exclusive development and commercialization rights to its norovirus vaccine candidate, HIL-214 formerly TAK-214, worldw 